Fig. 1
From: Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy
Common types of nanoparticles and their pathways through the body (A) and mechanisms of action of nanoparticles in tumor tissue (B)
Fig. 1 | Cancer Nanotechnology